long intergenic non-protein coding RNA 2774Genealiases: []
Q-omics provides the consensus-scored LINC02774 profile across patient tissues and cancer cell-line models. LINC02774 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in CESC. Among the 18 cancer types available for tumor–normal comparison, LINC02774 is differentially expressed in 6, with the highest sampling consensus in KICH. Additionally, LINC02774 RNA expression shows 14,121 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight CESC, KICH, and UVM as cancer lineages where LINC02774 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02774 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02774 survival associations across molecular data types. LINC02774 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02774 RNA expression–survival associations across cancer types. High LINC02774 expression shows unfavorable associations in KIRC, but favorable associations in CESC, LGG, BRCA, ESCA and LUAD. The CESC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify CESC as the clearest survival context for LINC02774 RNA expression.
This table summarizes LINC02774 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 6. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02774. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02774 shows lower tumor expression in KICH, THCA, LUSC and KIRC and higher tumor expression in BRCA and LIHC. The KICH box plot shows higher LINC02774 RNA expression in normal versus tumor tissue (log2 FC = −0.218, t-test p < 0.001).
This table shows molecular features associated with LINC02774 in patient tissues and cancer cell lines. In patient samples, LINC02774 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
